Sign Up Today and Learn More About Perceive Biotherapeutics Stock
Invest in or calculate the value of your shares in Perceive Biotherapeutics or other pre-IPO companies through EquityZen's platform.
Perceive Biotherapeutics Stock (PERB)
Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.
About Perceive Biotherapeutics Stock
Founded
2020
Headquarters
South San Francisco, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Perceive Biotherapeutics Press Mentions
Stay in the know about the latest news on Perceive Biotherapeutics
Catalio Capital Management Joins $15 Million Series A for Perceive Pharma
citybiz • Feb 20, 2025
Perceive Pharma Attracts $15M Series A Financing to Advance Ophthalmic Neuroprotection
prnewswire • Feb 18, 2025
Geographic Atrophy Clinical Trial Pipeline Insights | 23+ Key ...
medgadget • Dec 22, 2023
Geographic Atrophy Market to Boost Significantly, Assesses ...
prnewswire • Dec 22, 2023
The Week’s 10 Biggest Funding Rounds: SpaceX Takes Off In New Year; Netskope Secures $401M
news • Jan 06, 2023
Join now and verify your accreditation status to gain access to:
- Perceive Biotherapeutics Current Valuation
- Perceive Biotherapeutics Stock Price
- Perceive Biotherapeutics Management
- Available deals in Perceive Biotherapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Perceive Biotherapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Perceive Biotherapeutics Revenue and Financials
- Perceive Biotherapeutics Highlights
- Perceive Biotherapeutics Business Model
- Perceive Biotherapeutics Risk Factors
- Perceive Biotherapeutics Research Report from SACRA Research
Trading Perceive Biotherapeutics Stock
How to invest in Perceive Biotherapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Perceive Biotherapeutics through EquityZen funds. These investments are made available by existing Perceive Biotherapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Perceive Biotherapeutics stock?
Shareholders can sell their Perceive Biotherapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
